Phosphorylated c-Src predicts clinical outcome in triple negative breast cancers

Elsberger, B., Tovey, S., Tan, B., Brown, S., Brunton, V., Mallon, E., Cooke, T. and Edwards, J. (2009) Phosphorylated c-Src predicts clinical outcome in triple negative breast cancers. Cancer Research, 69(2), S179. (doi: 10.1158/0008-5472.SABCS-2076)

Full text not currently available from Enlighten.


Item Type:Articles
Additional Information:Abstract from the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 10-14 Dec 2008.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Edwards, Professor Joanne
Authors: Elsberger, B., Tovey, S., Tan, B., Brown, S., Brunton, V., Mallon, E., Cooke, T., and Edwards, J.
Subjects:R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Cancer Research
ISSN:0008-5472
ISSN (Online):1538-7445

University Staff: Request a correction | Enlighten Editors: Update this record